Understanding how older sexual and gender minorities in Nigeria decide to engage in anal cancer prevention.
Engaging Leaders to Elicit Viewpoints on Anal Cancer Prevention (ELDERS) study
This study is looking to understand how older LGBTQ+ individuals living with HIV in Nigeria feel about joining programs that help prevent anal cancer, so we can make these programs more appealing and accessible for them.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11020415 on NIH RePORTER |
What this research studies
This research focuses on older sexual and gender minorities (SGM) living with HIV in Nigeria, who are at a significantly higher risk for anal cancer. The study aims to gather insights from this demographic to understand their preferences and viewpoints regarding participation in anal cancer prevention programs. By identifying barriers such as privacy concerns and socioeconomic factors, the research seeks to tailor prevention strategies that resonate with older SGM. The ultimate goal is to enhance engagement in cancer screening among this high-risk group.
Who could benefit from this research
Good fit: Ideal candidates for this research are older sexual and gender minorities living with HIV in Nigeria, particularly those aged 45 and older.
Not a fit: Patients who do not identify as sexual or gender minorities or those who are not living with HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved anal cancer prevention strategies that effectively engage older sexual and gender minorities, potentially reducing their risk of developing advanced anal cancer.
How similar studies have performed: While this approach is tailored to a specific demographic, similar studies have shown success in engaging high-risk populations in cancer prevention through culturally sensitive strategies.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Nowak, Rebecca G. — University of Maryland Baltimore
- Study coordinator: Nowak, Rebecca G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.